希斯脱乙酶调节阿尔茨海默氏症患者的Tau功能
Subashchandrabose Chinnathambi1
1Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences Hospital (NIMHANS), Institute of National Importance, Bangalore, Karnataka, India.
Advances in protein chemistry and structural biology
|January 22, 2025
概括
阿尔茨海默病涉及粉样β和病理. 向基因组脱乙酶6 (HDAC6) 通过调节神经退行性疾病中的功能来提供一种潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默氏病 (AD) 是导致痴呆的主要原因,其特征是粉样β (Aβ) 斑块和由高酸化组成的神经纤维状结 (NFT).
- Aβ积累和疾病发作之间的确切关系,以及陶病在Aβ症状表现中的作用,仍然不清楚.
- 陶蛋白对微管稳定至关重要,但异常的翻译后修改,如高酸化,导致其聚合.
研究的目的:
- 在阿尔茨海默氏病的背景下,研究素脱乙酶6 (HDAC6) 在调节功能中的作用.
- 通过了解它对病理学的影响,探索HDAC6作为AD的潜在治疗点.
主要方法:
- 这项研究重点研究了HDAC6.6调节的酸化和乙化之间的竞争.
- 研究HDAC6对蛋白聚合和微管结合的功能影响.
主要成果:
- HDAC6的活动影响陶酸化和乙化,这是神经纤维状结形成的关键过程.
- 调节HDAC6功能可能会改变陶聚合,提供一种新的治疗途径.
结论:
- HDAC6在调节阿尔茨海默病的陶蛋白功能和病理学方面发挥着重要作用.
- 向HDAC6为AD提供了一个有前途的治疗策略,可能通过减轻与tau相关的神经退行症.
相关概念视频
Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439
Alzheimer's Disease: Treatment
160
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160
Histone Modification
13.0K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.0K
Spreading of Chromatin Modifications
8.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.2K
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Phosphorylation
49.8K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
49.8K


